KRAS and pancreatic neoplasm: Altogether, these data show that the E2F1-EP300 activator/co-activator complex is part of the novel signaling pathway controlling the promoter activity and, consequently, the expression of the autophagy-related gene VMP1 in pancreatic tumor cells carrying oncogenic KRAS.